Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.48 by 16.67 percent. This is a 24.44 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $418.761 million which beat the analyst consensus estimate of $418.647 million by 0.03 percent. This is a 0.76 percent increase over sales of $415.605 million the same period last year.